Exelixis
EXEL
#1458
Rank
C$21.14 B
Marketcap
C$85.32
Share price
1.42%
Change (1 day)
57.99%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company